{
    "_id": "2cdf16bf78b9426d99b0d356e3413d27",
    "_pm_abstract": [
        {
            "text": "Blockade of the cyclin-dependent kinase 4 and 6 pathway has been shown to be effective in the treatment of hormone receptor-positive advanced breast cancer (ABC). We report the interim results of DAWNA-1 ( NCT03927456 ), a double-blind, randomized, phase 3 trial of dalpiciclib (a new cyclin-dependent kinase 4 and 6 inhibitor) plus fulvestrant in hormone receptor-positive, HER2-negative ABC with disease progression after endocrine therapy. A total of 361 patients were randomized 2:1 to receive dalpiciclib plus fulvestrant or placebo plus fulvestrant. The study met the primary end point, showing significantly prolonged investigator-assessed progression-free survival with dalpiciclib plus fulvestrant versus placebo plus fulvestrant (median = 15.7, 95% confidence interval (CI) = 11.1-not reached versus 7.2, 95% CI = 5.6-9.2 months; hazard ratio = 0.42, 95% CI = 0.31-0.58; one-sided P < 0.0001 (boundary was P ≤ 0.008)). The most common grade 3 or 4 adverse events with dalpiciclib plus fulvestrant were neutropenia (84.2%) and leukopenia (62.1%). The incidence of serious adverse events was 5.8% with dalpiciclib plus fulvestrant versus 6.7% with placebo plus fulvestrant. Our findings support dalpiciclib plus fulvestrant as a new treatment option for pretreated hormone receptor-positive, HER2-negative ABC."
        }
    ],
    "_pm_abstract_raw": "Blockade of the cyclin-dependent kinase 4 and 6 pathway has been shown to be effective in the treatment of hormone receptor-positive advanced breast cancer (ABC). We report the interim results of DAWNA-1 ( NCT03927456 ), a double-blind, randomized, phase 3 trial of dalpiciclib (a new cyclin-dependent kinase 4 and 6 inhibitor) plus fulvestrant in hormone receptor-positive, HER2-negative ABC with disease progression after endocrine therapy. A total of 361 patients were randomized 2:1 to receive dalpiciclib plus fulvestrant or placebo plus fulvestrant. The study met the primary end point, showing significantly prolonged investigator-assessed progression-free survival with dalpiciclib plus fulvestrant versus placebo plus fulvestrant (median = 15.7, 95% confidence interval (CI) = 11.1-not reached versus 7.2, 95% CI = 5.6-9.2 months; hazard ratio = 0.42, 95% CI = 0.31-0.58; one-sided P < 0.0001 (boundary was P ≤ 0.008)). The most common grade 3 or 4 adverse events with dalpiciclib plus fulvestrant were neutropenia (84.2%) and leukopenia (62.1%). The incidence of serious adverse events was 5.8% with dalpiciclib plus fulvestrant versus 6.7% with placebo plus fulvestrant. Our findings support dalpiciclib plus fulvestrant as a new treatment option for pretreated hormone receptor-positive, HER2-negative ABC.",
    "_pm_id": "34737452",
    "_pm_title": "Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial.",
    "_umls_result": [
        {
            "_semantic_type": "Therapeutic or Preventive Procedure",
            "all_matches": [
                {
                    "_term": "placebo",
                    "concepts": [
                        "('C0032042', 'Placebo', 'Therapeutic or Preventive Procedure', 'PT', 'PSY')",
                        "('C0032042', 'Placebo', 'Therapeutic or Preventive Procedure', 'PT', 'NCI')",
                        "('C0032042', 'placebo', 'Therapeutic or Preventive Procedure', 'PT', 'CSP')",
                        "('C0032042', 'placebo', 'Therapeutic or Preventive Procedure', 'SY', 'CHV')",
                        "('C0032042', 'Placebo', 'Therapeutic or Preventive Procedure', 'DN', 'NCI_CTRP')",
                        "('C0032042', 'placebo', 'Therapeutic or Preventive Procedure', 'PT', 'NCI_NCI-GLOSS')",
                        "('C0032042', 'placebo', 'Therapeutic or Preventive Procedure', 'PT', 'NCI_CDISC-GLOSS')",
                        "('C0032042', 'placebo', 'Therapeutic or Preventive Procedure', 'PT', 'PDQ')"
                    ]
                },
                {
                    "_term": "abc",
                    "concepts": [
                        "('C4552790', 'ABC', 'Therapeutic or Preventive Procedure', 'SY', 'NCI')"
                    ]
                },
                {
                    "_term": "endocrine therapy",
                    "concepts": [
                        "('C0279025', 'endocrine therapy', 'Therapeutic or Preventive Procedure', 'PT', 'PDQ')",
                        "('C0279025', 'Endocrine therapy', 'Therapeutic or Preventive Procedure', 'SY', 'SNOMEDCT_US')",
                        "('C0279025', 'endocrine therapy', 'Therapeutic or Preventive Procedure', 'PT', 'NCI_NCI-GLOSS')",
                        "('C0279025', 'Endocrine Therapy', 'Therapeutic or Preventive Procedure', 'SY', 'NCI_caDSR')"
                    ]
                }
            ]
        },
        {
            "_semantic_type": "Neoplastic Process",
            "all_matches": [
                {
                    "_term": "advanced breast cancer",
                    "concepts": [
                        "('C3495917', 'Advanced breast cancer', 'Neoplastic Process', 'LLT', 'MDR')"
                    ]
                },
                {
                    "_term": "breast cancer",
                    "concepts": [
                        "('C0678222', 'Breast Cancer', 'Neoplastic Process', 'DN', 'NCI_CTRP')",
                        "('C0678222', 'breast cancer', 'Neoplastic Process', 'PT', 'NCI_NCI-GLOSS')",
                        "('C0678222', 'Breast Cancer', 'Neoplastic Process', 'PT', 'NCI_FDA')",
                        "('C0006142', 'breast cancer', 'Neoplastic Process', 'SY', 'MEDCIN')",
                        "('C0006142', 'Breast cancer', 'Neoplastic Process', 'LA', 'LNC')",
                        "('C0006142', 'breast cancer', 'Neoplastic Process', 'ET', 'CSP')",
                        "('C0006142', 'Breast Cancer', 'Neoplastic Process', 'PT', 'MEDLINEPLUS')",
                        "('C0006142', 'breast cancer', 'Neoplastic Process', 'PSC', 'PDQ')",
                        "('C0678222', 'Breast Cancer', 'Neoplastic Process', 'PT', 'NCI_NICHD')",
                        "('C0006142', 'Breast Cancer', 'Neoplastic Process', 'PEP', 'MSH')",
                        "('C0678222', 'Breast Cancer', 'Neoplastic Process', 'PT', 'NCI_CTRP')",
                        "('C3897071', 'Breast Cancer', 'Neoplastic Process', 'DN', 'NCI_CTRP')",
                        "('C0678222', 'Breast cancer', 'Neoplastic Process', 'SY', 'HPO')",
                        "('C0006142', 'Breast cancer', 'Neoplastic Process', 'PT', 'MDR')",
                        "('C0678222', 'Breast Cancer', 'Neoplastic Process', 'PT', 'NCI_GDC')",
                        "('C0678222', 'Breast Cancer', 'Neoplastic Process', 'SY', 'NCI')",
                        "('C0006142', 'breast cancer', 'Neoplastic Process', 'PT', 'CHV')",
                        "('C0006142', 'BREAST CANCER', 'Neoplastic Process', 'PT', 'OMIM')",
                        "('C0678222', 'breast cancer', 'Neoplastic Process', 'PT', 'CHV')",
                        "('C0006142', 'Breast cancer', 'Neoplastic Process', 'LLT', 'MDR')",
                        "('C0006142', 'breast cancer', 'Neoplastic Process', 'PT', 'MEDCIN')",
                        "('C0006142', 'Breast cancer', 'Neoplastic Process', 'PTCS', 'OMIM')",
                        "('C0006142', 'Breast cancer', 'Neoplastic Process', 'SY', 'SNOMEDCT_US')"
                    ]
                },
                {
                    "_term": "progression",
                    "concepts": [
                        "('C0178874', 'Progression', 'Neoplastic Process', 'PT', 'NCI_GDC')"
                    ]
                },
                {
                    "_term": "grade 3",
                    "concepts": [
                        "('C0079745', 'Grade 3', 'Neoplastic Process', 'SY', 'NCI_caDSR')"
                    ]
                }
            ]
        },
        {
            "_semantic_type": "Finding",
            "all_matches": [
                {
                    "_term": "randomized",
                    "concepts": [
                        "('C3815594', 'RANDOMIZED', 'Finding', 'PT', 'NCI_CDISC')"
                    ]
                },
                {
                    "_term": "disease progression",
                    "concepts": [
                        "('C5239280', 'Disease Progression', 'Finding', 'PT', 'NCI_PCDC')",
                        "('C4552808', 'Disease progression', 'Finding', 'PT', 'NCI_CTCAE_5')"
                    ]
                },
                {
                    "_term": "endocrine",
                    "concepts": [
                        "('C1559198', 'ENDOCRINE', 'Finding', 'PT', 'NCI_CTCAE_3')",
                        "('C0559306', 'Endocrine', 'Finding', 'PT', 'NCI_ACC-AHA')"
                    ]
                },
                {
                    "_term": "grade 3",
                    "concepts": [
                        "('C0450094', 'Grade 3', 'Finding', 'PT', 'SNOMEDCT_US')",
                        "('C0450094', 'Grade 3', 'Finding', 'LA', 'LNC')",
                        "('C1519275', 'Grade 3', 'Finding', 'SY', 'NCI_CDISC')",
                        "('C1519275', 'Grade 3', 'Finding', 'PT', 'NCI_PCDC')",
                        "('C1519275', 'Grade 3', 'Finding', 'PT', 'NCI_GDC')"
                    ]
                },
                {
                    "_term": "neutropenia",
                    "concepts": [
                        "('C0853697', 'neutropenia', 'Finding', 'PT', 'NCI_NCI-GLOSS')",
                        "('C0853697', 'Neutropenia', 'Finding', 'DN', 'NCI_CTRP')",
                        "('C0853697', 'Neutropenia', 'Finding', 'PT', 'SNOMEDCT_US')",
                        "('C0853697', 'Neutropenia', 'Finding', 'PT', 'NCI')",
                        "('C0853697', 'Neutropenia', 'Finding', 'PT', 'NCI_NICHD')",
                        "('C0853697', 'Neutropenia', 'Finding', 'PT', 'NCI_CELLOSAURUS')",
                        "('C0853697', 'Neutropenia', 'Finding', 'PT', 'HPO')"
                    ]
                },
                {
                    "_term": "leukopenia",
                    "concepts": [
                        "('C0750394', 'Leukopenia', 'Finding', 'PT', 'NCI')",
                        "('C0750394', 'Leukopenia', 'Finding', 'PT', 'NCI_NICHD')",
                        "('C0750394', 'leukopenia', 'Finding', 'PT', 'NCI_NCI-GLOSS')"
                    ]
                },
                {
                    "_term": "treatment option",
                    "concepts": [
                        "('C0683525', 'treatment option', 'Finding', 'PT', 'CHV')"
                    ]
                }
            ]
        },
        {
            "_semantic_type": "Pathologic Function",
            "all_matches": [
                {
                    "_term": "disease progression",
                    "concepts": [
                        "('C0242656', 'Disease progression', 'Pathologic Function', 'LLT', 'MDR')",
                        "('C0242656', 'Disease progression', 'Pathologic Function', 'LA', 'LNC')",
                        "('C0242656', 'Disease Progression', 'Pathologic Function', 'PT', 'NCI_PCDC')",
                        "('C0242656', 'Disease Progression', 'Pathologic Function', 'PT', 'NCI')",
                        "('C0242656', 'Disease Progression', 'Pathologic Function', 'PT', 'NCI_GDC')",
                        "('C0242656', 'Disease Progression', 'Pathologic Function', 'PN', 'MTH')",
                        "('C0242656', 'Disease Progression', 'Pathologic Function', 'SY', 'NCI_caDSR')",
                        "('C0242656', 'disease progression', 'Pathologic Function', 'ET', 'CSP')",
                        "('C0242656', 'Disease Progression', 'Pathologic Function', 'MH', 'MSH')",
                        "('C1947901', 'disease progression', 'Pathologic Function', 'SY', 'NCI_NCI-GLOSS')",
                        "('C0242656', 'Disease progression', 'Pathologic Function', 'PT', 'MDR')",
                        "('C0242656', 'disease progression', 'Pathologic Function', 'PT', 'CHV')"
                    ]
                },
                {
                    "_term": "progression",
                    "concepts": [
                        "('C0242656', 'progression', 'Pathologic Function', 'PT', 'NCI_NCI-GLOSS')",
                        "('C0242656', 'Progression', 'Pathologic Function', 'SY', 'NCI')",
                        "('C1947901', 'progression', 'Pathologic Function', 'SY', 'NCI_NCI-GLOSS')"
                    ]
                },
                {
                    "_term": "adverse events",
                    "concepts": [
                        "('C0877248', 'adverse events', 'Pathologic Function', 'SY', 'CHV')"
                    ]
                }
            ]
        },
        {
            "_semantic_type": "Disease or Syndrome",
            "all_matches": [
                {
                    "_term": "disease progression",
                    "concepts": [
                        "('C1335499', 'Disease Progression', 'Disease or Syndrome', 'SY', 'NCI_CDISC')"
                    ]
                },
                {
                    "_term": "grade 3",
                    "concepts": [
                        "('C3889290', 'GRADE 3', 'Disease or Syndrome', 'PT', 'NCI_CDISC')"
                    ]
                },
                {
                    "_term": "neutropenia",
                    "concepts": [
                        "('C0027947', 'neutropenia', 'Disease or Syndrome', 'PT', 'MEDCIN')",
                        "('C0027947', 'neutropenia', 'Disease or Syndrome', 'PT', 'PDQ')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'MH', 'MSH')",
                        "('C0027947', 'neutropenia', 'Disease or Syndrome', 'PT', 'CSP')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'LLT', 'MDR')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'PT', 'ICPC2P')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'PTCS', 'OMIM')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'ID', 'NOC')",
                        "('C0027947', 'neutropenia', 'Disease or Syndrome', 'PTN', 'ICPC2P')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'HT', 'ICD9CM')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'HT', 'ICD10CM')",
                        "('C0027947', 'neutropenia', 'Disease or Syndrome', 'PT', 'CHV')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'PN', 'MTH')",
                        "('C0027947', 'neutropenia', 'Disease or Syndrome', 'PT', 'ICPC2ICD10ENG')",
                        "('C0027947', 'Neutropenia', 'Disease or Syndrome', 'PT', 'MDR')"
                    ]
                },
                {
                    "_term": "leukopenia",
                    "concepts": [
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'PT', 'MDR')",
                        "('C0023530', 'leukopenia', 'Disease or Syndrome', 'PT', 'CHV')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'RT', 'NANDA-I')",
                        "('C0023530', 'leukopenia', 'Disease or Syndrome', 'PT', 'ICPC2ICD10ENG')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'MH', 'MSH')",
                        "('C0023530', 'leukopenia', 'Disease or Syndrome', 'PT', 'MEDCIN')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'ET', 'ICD10CM')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'PT', 'SNOMEDCT_US')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'LLT', 'MDR')",
                        "('C0023530', 'leukopenia', 'Disease or Syndrome', 'PT', 'MTH')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'PT', 'ICPC2P')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'PTCS', 'OMIM')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'PT', 'HPO')",
                        "('C0023530', 'leukopenia', 'Disease or Syndrome', 'PT', 'CSP')",
                        "('C0023530', 'leukopenia', 'Disease or Syndrome', 'PTN', 'ICPC2P')",
                        "('C0023530', 'Leukopenia', 'Disease or Syndrome', 'PN', 'MTH')"
                    ]
                }
            ]
        },
        {
            "_semantic_type": "Patient or Disabled Group",
            "all_matches": [
                {
                    "_term": "patients",
                    "concepts": [
                        "('C0030705', 'patients', 'Patient or Disabled Group', 'SY', 'CHV')",
                        "('C0030705', 'Patients', 'Patient or Disabled Group', 'PT', 'PSY')",
                        "('C0030705', 'Patients', 'Patient or Disabled Group', 'PT', 'LCH_NW')",
                        "('C0030705', 'Patients', 'Patient or Disabled Group', 'PN', 'MTH')",
                        "('C0030705', 'Patients', 'Patient or Disabled Group', 'MH', 'MSH')",
                        "('C0030705', 'Patients', 'Patient or Disabled Group', 'SY', 'NCI')"
                    ]
                }
            ]
        },
        {
            "_semantic_type": "Clinical Attribute",
            "all_matches": [
                {
                    "_term": "findings",
                    "concepts": [
                        "('C2926606', 'Findings', 'Clinical Attribute', 'OSN', 'LNC')"
                    ]
                }
            ]
        }
    ],
    "bio_labels": [
        "激素受体阳性",
        "HER2阴性"
    ],
    "bio_labels_en": [
        "hormone receptor-positive",
        "HER2-negative"
    ],
    "biomarker": [
        "ab98606ef7a54762b5aa49b2512d8e0f"
    ],
    "clinical_stage": null,
    "disease_labels": [
        "局部晚期",
        "转移性"
    ],
    "disease_labels_en": [
        "Locally advanced",
        " Metastatic"
    ],
    "indications": [
        {
            "_id": "141",
            "ct_disease": [
                "Breast Neoplasms",
                "Breast Neoplasms, Male",
                "Breast Cancer, Male",
                "Breast Carcinoma In Situ",
                "Carcinoma, Ductal, Breast",
                "Breast Cancer Female"
            ],
            "department": [
                "肿瘤科"
            ],
            "indication_type": [
                "肿瘤领域"
            ],
            "name": "乳腺癌",
            "name_en": "breast cancer",
            "name_short": "",
            "name_synonyms": [
                "breast tumor",
                "neoplasia of the breast",
                "neoplasm of breast",
                "tumours of the breast",
                "neoplasm of the breast",
                "breast neoplasm"
            ],
            "parent_indication": [
                "133"
            ],
            "state": "正常"
        }
    ],
    "m_stage": null,
    "n_stage": null,
    "pathology": null,
    "patient_labels": [
        "18-75岁",
        "ECOG PS 0-1",
        "排除既往接受过CDK4/6抑制剂，依维莫司或氟维斯特的患者"
    ],
    "patient_labels_en": [
        "18-75 years",
        "ECOG PS 0-1",
        "excluded patients who received prior treatment with any CDK4/6 inhibitor, everolimus or fulvestant"
    ],
    "t_stage": null,
    "therapy_labels": [
        "二线及以上治疗"
    ],
    "therapy_labels_en": [
        "Second and later lines therapy"
    ],
    "title_abbr": "SHR6390-III-301"
}